| Financial Year |
March 31 2023 |
| Monetary Funds |
1,034,349,602.95 |
| Held-for-trading Financial Assets |
608,756,717.87 |
| Notes Receivable |
-- |
| Accounts Receivable |
379,718,930.21 |
| Advances to Suppliers |
13,395,300.24 |
| Other Receivables |
6,160,259.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
671,304,336.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
345,726,049.86 |
| Total Current Assets |
3,169,230,178.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,525,135.71 |
| Investment Properties |
208,585,927.67 |
| Fixed Assetes |
1,139,833,502.53 |
| Under-construction Projects |
83,384,475.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,462,305.57 |
| R&D expenses |
35,044,094.63 |
| Goodwill |
7,500,892.68 |
| Long-Term Deferred and Prepaid Expenses |
810,146.85 |
| Deferred Income Tax Assets |
13,671,759.91 |
| Other Non-Current Assets |
106,795,147.37 |
| Sub-Total of Non-Current Assets |
1,891,845,168.69 |
| Total Assets |
5,061,075,347.27 |
| Short-Term Loans |
223,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,000,000.00 |
| Accounts Payable |
339,910,786.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,092,608.97 |
| Taxes Payable |
14,420,158.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,330,190.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,257,223.95 |
| Other Current Liabilities |
3,815,996.20 |
| Sub-Total of Current Liabilities |
800,597,855.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,979,826.68 |
| Deferred Income Tax Liabilities |
19,673,955.64 |
| Other Non-Current Liabilities |
6,000,000.00 |
| Sub-Total of Non-Current Liabilities |
80,977,527.84 |
| Total Liabilities |
881,575,383.43 |
| Paid-In Capital(Or Share Stock) |
700,000,000.00 |
| Capital Surplus |
1,144,722,827.57 |
| Surplus Reserve |
335,497,566.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,976,577,146.25 |
| Minority Stockholder's Interest |
22,526,919.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,156,973,044.56 |
| Owner's Equity（Stockholder's Equity） |
4,179,499,963.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,061,075,347.27 |
